Credent Global Finance’s Board approved a proposal to raise up to ₹35 crore through issuance of equity shares or convertible securities via Qualified Institutions Placement (QIP), subject to shareholders' approval. Socradamus Capital appointed as lead manager to facilitate the fundraising process.
In its meeting held on October 10, 2025, the Board of Directors of Credent Global Finance Limited approved a significant capital raising initiative aimed at bolstering the company's financial position. This fundraising will be executed through the issuance of equity shares or equity-linked securities, including convertible or exchangeable instruments, via Qualified Institutions Placement (QIP). The total amount targeted for this issuance is up to ₹3,500 Lakhs (₹35 crore), subject to regulatory approvals and the consent of the company's shareholders.
This move allows for flexibility in the type and mode of issuance — apart from QIP, the company may consider preferential allotment, private placement, or any other permitted method to achieve the target fundraise in one or more tranches. Pricing for these securities will align with applicable market laws and regulations to ensure compliance.
Key to managing this capital raising exercise, the Board has appointed M/s Socradamus Capital Private Limited as the Book Running Lead Manager (BRLM). Socradamus Capital is expected to orchestrate the offering, leveraging its expertise in capital markets and merchant banking services.
This fundraising initiative marks a strategic step for Credent Global Finance to strengthen its capital base, optimize its financial structure, and support future growth plans amid evolving market conditions.
Key Highlights
-
Board approval granted for raising up to ₹3,500 Lakhs via QIP or other equity-linked instruments.
-
Fundraising via multiple possible routes: QIP, preferential issue, private placement, or combinations thereof.
-
Pricing of securities to comply with SEBI and other legal regulations.
-
Socradamus Capital Private Limited appointed as the lead manager for the issue.
-
Shareholder and regulatory approvals required before execution.
The company’s funding plans come as an essential leverage to pursue business expansion and meet capital requirements, emphasizing transparency and adherence to regulatory norms.
Sources: Credent Global Finance Ltd Board Meeting Announcement, Socradamus Capital Private Limited disclosure, SEBI Listing Regulations Disclosure.